Elena Bresin - Concepedia

Author

Elena Bresin

Mario Negri Institute for Pharmacological Research ORCID

Also Known As

Bresin, E., Bresin, Elena, E. Bresin, Elena Bresin, Elena, Bresin

Publications

5.6K

Citations

H-Index

Concepts

All Affiliations

Mario Negri Institute for Pharmacological Research Istituti di Ricovero e Cura a Carattere Scientifico University of Milan Ospedale Papa Giovanni XXIII University of Verona

About

Elena Bresin is an author at Mario Negri Institute for Pharmacological Research specializing in medicine, pathology, and autoimmune disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	20	1.8K
2	Immunology	12	12	1.2K
3	Engineering	1	1	33
4	Health Sciences	1	1	18
5	Public Health	1	1	140

Elena Bresin

Publications

5.2K

Citations

H-Index

Page 1

	Year	Citations
Relative Role of Genetic Complement Abnormalities in Sporadic and Familial aHUS and Their Impact on Clinical Phenotype Marina Noris, Jessica Caprioli, Elena Bresin, Clinical Journal of the American Society of Nephrology	2010	1K
Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome Jessica Caprioli, Marina Noris, Simona Brioschi, Blood	2006	729
Combined Complement Gene Mutations in Atypical Hemolytic Uremic Syndrome Influence Clinical Phenotype Elena Bresin, Erica Rurali, Jessica Caprioli, Journal of the American Society of Nephrology	2013	344
Dynamics of complement activation in aHUS and how to monitor eculizumab therapy Marina Noris, Miriam Galbusera, Sara Gastoldi, Blood	2014	327
Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease Jessica Caprioli, Federica Castelletti, Sara Bucchioni, Human Molecular Genetics HlaHistocompatibilityHf1 MutationsComplete Hf1Genetic Epidemiology	2003	306
Hemolytic Uremic Syndrome in Pregnancy and Postpartum Alexandra Bruel, David Kavanagh, Marina Noris, Clinical Journal of the American Society of Nephrology	2017	212
von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome Giuseppe Remuzzi, Miriam Galbusera, Marina Noris, Blood	2002	192
Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome Paraskevas Iatropoulos, Marina Noris, Caterina Mele, Molecular Immunology Glomerular DiseaseRenal PathologyGenetic EpidemiologyImmunologyPathology	2016	177
Mutations in <i>FN1</i> cause glomerulopathy with fibronectin deposits Federica Castelletti, Roberta Donadelli, Federica Banterla, Proceedings of the National Academy of Sciences Glomerular DiseaseFn1 MutationGeneticsRenal PathologyPathology	2008	152
Autosomal-dominant Alport syndrome: Natural history of a disease due to COL4A3 or COL4A4 gene Chiara Pescucci, Francesca Mari, Ilaria Longo, Kidney International Autosomal-dominant Alport SyndromeMendelian DisorderAutoimmune DiseaseGenetic DisorderGenetics	2004	150

Page 1